VALIDATION OF THE MASEF SCORE FOR ITS DIAGNOSTIC ENRICHMENT UTILITY FOR AT-RISK MASH IN THE NIMBLE PROJECT

被引：0

作者：

Kanagalingam, Gowthami ^{[1
]}

Shankar, Sudha ^{[2
]}

Yates, Katherine ^{[3
]}

Calle, Roberto ^{[4
]}

Pasek, Alex ^{[5
]}

Dehn, Clayton ^{[6
]}

Sirlin, Claude ^{[7
]}

Samir, Anthony ^{[8
]}

Middleton, Michael ^{[7
]}

Pierce, Theodore ^{[9
]}

Fowler, Kathryn ^{[7
]}

Sherlock, Sarah ^{[10
]}

Kamphaus, Tania ^{[5
]}

Siddiqui, Mohammad ^{[1
]}

Kowdley, Kris ^{[11
]}

Diehl, Anna Mae ^{[12
]}

Hatfield, Bryce ^{[1
]}

Loomba, Rohit ^{[13
]}

Sanyal, Arun ^{[1
]}

机构：

[1] Virginia Commonwealth Univ, Richmond, VA 23284 USA

[2] Pfizer, New York, NY USA

[3] Johns Hopkins Univ, Baltimore, MD 21218 USA

[4] Regeneron Pharmaceut, Tarrytown, NY USA

[5] FNIH, North Bethesda, MD USA

[6] P Value LLC, Cedar Knolls, NJ USA

[7] Univ Calif San Diego, La Jolla, CA 92093 USA

[8] Harvard Med Sch, Boston, MA 02115 USA

[9] Harvard Univ, Cambridge, MA 02138 USA

[10] AstraZeneca, Cambridge, England

[11] Liver Inst Northwest, Seattle, WA USA

[12] Duke Univ, Sch Med, Durham, NC 27706 USA

[13] Univ Calif San Diego, Sch Med, San Diego, CA USA

来源：

HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2597

引用

页码：S1962 / S1964

页数：3

共 50 条

[21] The utility of the MAGGIC heart failure risk score in predicting response to spironolactone: validation and results from the TOPCAT trial
Silverman, D. Daniel
Baldridge, A.
Shah, S.
EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 398 - 399
[22] Does my patient have chronic Chagas disease? Development and temporal validation of a diagnostic risk score
Alvarenga Americano do Brasil, Pedro Emmanuel
Xavier, Sergio Salles
Holanda, Marcelo Teixeira
Hasslocher-Moreno, Alejandro Marcel
Braga, Jose Ueleres
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2016, 49 (03) : 329 - 340
[23] Point of Care Clinical Risk Score to Improve the Negative Diagnostic Utility of an Agatston Score of Zero Averting the Need for Coronary Computed Tomography Angiography
Alshahrani, Ali M.
Mahmood, Hamza
Wells, George A.
Hossein, Alomgir
Rybicki, Frank J.
Achenbach, Stephan
Al-Mallah, Mouaz H.
Andreini, Daniele
Bax, Jeroen J.
Berman, Daniel S.
Budoff, Matthew J.
Cademartiri, Filippo
Callister, Tracy Q.
Chang, Hyuk-Jae
Chinnaiyan, Kavitha
Cury, Ricardo C.
DeLego, Augustin
Feuchtner, Gudrun
Hadamitzky, Martin
Hausleiter, Joerg
Kaufmann, Philipp A.
Kim, Yong-lin
Leipsic, Jonathon A.
Maffei, Erica
Marques, Hugo
Pontone, Gianluca
Raff, Gilbert
Rubinshtein, Ronen
Shaw, Leslee J.
Villines, Todd C.
Lin, Fay Y.
Min, James K.
Chow, Benjamin J.
CIRCULATION-CARDIOVASCULAR IMAGING, 2019, 12 (09)
[24] Genetic risk score of clock resilience and its utility in predicting individual vulnerability to night work and chronic disease risk
Zebrowska, Magdalena
JOURNAL OF SLEEP RESEARCH, 2024, 33
[25] SINGLE NUCLEOTIDE POLYMORPHISMS AND RISK OF PROSTATE CANCER: DEVELOPMENT AND VALIDATION OF A NOVEL GENETIC RISK SCORE FOR INDIVIDUALIZED SCREENING AND DIAGNOSTIC PROGRAMMES
Cucchiara, Vito
Mirone, Vincenzo
Lazarevic, Dejan
Cittaro, Davide
Tonon, Giovanni
Zoccolillo, Matteo
Bianchi, Marco Emilio
Gandaglia, Giorgio
Fossati, Nicola
Shariat, Shahrokh F.
Montorsi, Francesco
Briganti, Alberto
JOURNAL OF UROLOGY, 2018, 199 (04): : E1111 - E1112
[26] Diagnostic performance of the fibrosis-4 index and the NAFLD fibrosis score for screening at-risk individuals in a health check-up setting
Park, Huiyul
Yoon, Eileen L.
Kim, Mimi
Lee, Jonghyun
Kim, Hye-Lin
Cho, Seon
Nah, Eun-Hee
Jun, Dae Won
HEPATOLOGY COMMUNICATIONS, 2023, 7 (10)
[27] Reexamination Of A Risk Score For Severity Of Acute Exacerbations Of Chronic Obstructive Pulmonary Disease And Its Utility In Identifying Low Risk Patients
Baig, H.
Alsaleh, L.
Rathi, K.
Adwani, S.
Yuan, C.
Gllava, I.
Abusaada, K.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[28] IMPROVED DIAGNOSTIC ACCURACY OF VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY BASED TESTS IN IDENTIFYING METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) AND AT-RISK MASH IN OBESE AND LEAN INDIVIDUALS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
Quek, Joo Wei Ethan
Tan, En Ying
Lee, Shi Yan
Huang, Daniel
Lee, Jonathan
Teng, Margaret
Ng, Cheng Han
Syn, Nicholas
Wee, Aileen
Soon, Shook Ting Gwyneth
Jumat, Nur Halisah
Dan, Yock Young
Muthiah, Mark
HEPATOLOGY, 2024, 80 : S620 - S621
[29] Validation of the HellenicSCORE (a Calibration of the ESC SCORE Project) Regarding 10-Year Risk of Fatal Cardiovascular Disease in Greece
Panagiotakos, Demosthenes B.
Georgousopoulou, Ekavi N.
Fitzgerald, Anthony P.
Pitsavos, Christos
Stefanadis, Christodoulos
HELLENIC JOURNAL OF CARDIOLOGY, 2015, 56 (04) : 302 - 308
[30] Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies
Xu, Jianfeng
Resurreccion, W. Kyle
Shi, Zhuqing
Wei, Jun
Wang, Chi-Hsiung
Zheng, S. Lilly
Hulick, Peter J.
Ross, Ashley E.
Pavlovich, Christian P.
Helfand, Brian T.
Isaacs, William B.
PROSTATE CANCER AND PROSTATIC DISEASES, 2022, 25 (03) : 422 - 430

← 1 2 3 4 5 →